Glenn has a first degree in Genetics from The University of Nottingham and a D.Phil in Immunology from Oxford University. Following a period of post-doctoral research, Glenn joined Ernst & Young and qualified as a chartered accountant. He then spent several years in Palo Alto, Ca. as part of Ernst & Young’s biotech practice working with companies at varying stages of development. Glenn has been Chief Executive of BioCity since 2003.
Genetics, Immunology